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Model of PCP regulation of directed 
neuron migration. Inter-cellular 
communication between Vangl2 and 
Fzd3a activates the activity of each 
protein within motile neurons. When 
Vangl2 is activated in the neuron by 
Fzd3a on an epithelial cell, the neuron’s 
filopodia are destabilized. When Fzd3a 
in the neuron contacts Vangl2 on an 
epithelial cell, the filopodia of the 
neuron are stabilized. In this way, the 
polarity of the underlying epithelium can 
direct the movement of migrating cells. 
 
The planar cell polarity pathway (PCP) is a mechanism of communicating polarity cues by cell-to-cell 
contact. The components of this pathway are conserved among vertebrates and invertebrates 
allowing for their study in model organisms such as optically clear zebrafish embryos. Mechanisms 
that establish the stereotypical position of planar cell polarity proteins in static epithelial cells have 
been well studied. However, little is known about the role of planar cell polarity signaling in motile 
cells such as migrating neurons in the developing embryo.  Scientists in the Moens Laboratory 
(Basic Sciences Division) set out to investigate whether planar cell polarity signaling was required for 
the movement of the facial branchiomotor neurons (FBMNs) in zebrafish embryos. The results of 
their study were recently published in PLOS Genetics.   
To begin, PCP signaling was altered within the FBMNs in several different ways to evaluate the 
effect on migration. A dominant-negative PCP-specific component of the Wnt pathway, called Dvl-
DEP, was expressed exclusively in the FBMNs themselves. When this construct was expressed, 
fluorescently labeled neurons stayed near their origin and did not migrate out of rhombomere 
(segment) 4 as they would have in wild type animals.  Additionally, specific loss of expression of the 
PCP gene Vangl2 in FBMNs also prevented migration. It was previously shown that PCP signaling 
requires inter-cellular communication, so the authors investigated whether PCP signaling 
components need to be expressed in cells surrounding the migrating FBMNs. Wild-type FBMNs 
were transplanted into fish expressing the dominant-negative mutant PCP protein Dvl-DEP in 
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rhombomere 4. In contrast to neurons transplanted into wild-type hosts, the neurons transplanted 
into Dvl-DEP r4 mutant hosts failed to migrate out of r4. Thus, expression of PCP components is 
required within the FBMNs as well as in the cells of the migratory environment.   
In order to visualize PCP proteins within cells in their native environment, the scientists turned to 
spinning disc confocal microscopy. Mosaic expression of fluorescently labeled PCP proteins allowed 
researchers to visualize polarized PCP protein localization within single, young FBMNs in r4 as well 
as in cells of the floorplate beneath them. While monitoring migrating FBMNs, a weak but detectable 
accumulation of the PCP protein Vangl2 was observed at the tips of filopodia prior to retraction. 
Filopodia are dynamic protrusions of migrating cells that contribute to physical movement. Given the 
lack of migration in PCP mutant neurons and embryos, as well as the accumulation of Vangl2 at 
retracting tips, the scientists characterized the effects of mutating PCP components on filopodial 
dynamics. Filopodia of FBMNs in vangl2 mutant animals were longer lived while filopodia in a fzd3a 
mutant were shorter lived. These effects on filopodia stability disappeared when FBMNs were 
dissected out of embryos and monitored in vitro. Thus, expression of Vangl2 and Fzd3a in the 
FBMNs and in cells in their environment is required for normal filopodial dynamics. 
In order to further characterize the role of PCP signaling in epithelial cells in the environment, 
transplant experiments placing wild-type neurons into mutant hosts were carried out.  Wild-type 
FBMNs transplanted into vangl2 mutant hosts had short lived filopodia while the wild-type FBMN 
filopodia in fzd3a mutant hosts were longer lived. This is the opposite effect than observed from 
neurons that originated in vangl2 and fzd3a mutant hosts. This led the scientists to conclude that 
there is an antagonistic relationship between Vangl2 and Fzd3a on filopodia stability, such that 
Fzd3a and Vangl2 in surrounding epithelial cells activate the intracellular activities of Vangl2 and 
Fzd3a, respectively. Therefore, Vangl2 protein in wild-type neurons transplanted into vangl2 mutant 
hosts can be activated by environmental Fzd3a and destabilize filopodia, which is consistent with the 
appearance of longer-lived filopodia in vangl2 negative mutant neurons.  
  
While this is the first description of an antagonistic relationship between Vangl2 and Fzd3a in moving 
cells, it fits in with previous studies of these proteins. For example, it has been observed that Vangl1 
and Fzd6 in metastatic breast cancer cells localize to exclusive locations on the cell surface and that 
preventing expression of either one inhibits cell movement2.  Together, these multiple lines of 
evidence suggest a mechanism whereby polarity cues are communicated to migrating cells through 
interactions between planar polarity proteins to ensure that cells move in a specific direction. 
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